Module Specifications.
Current Academic Year 2024 - 2025
All Module information is indicative, and this portal is an interim interface pending the full upgrade of Coursebuilder and subsequent integration to the new DCU Student Information System (DCU Key).
As such, this is a point in time view of data which will be refreshed periodically. Some fields/data may not yet be available pending the completion of the full Coursebuilder upgrade and integration project. We will post status updates as they become available. Thank you for your patience and understanding.
Date posted: September 2024
| |||||||||||||||||||||||||||||||||||||||||||
None |
|||||||||||||||||||||||||||||||||||||||||||
Description To describe and explain the essentials of psychopharmacology, i.e., how psychoactive drugs interact with the body and the brain, and how psychoactive drugs are used to treat neuropsychological/psychiatric conditions and disorders | |||||||||||||||||||||||||||||||||||||||||||
Learning Outcomes 1. Explain the basic principles of psychopharmacology 2. Describe and revise the structure and function of the nervous system 3. Describe and revise the main principles of synaptic transmission and signal transduction 4. Describe and explain the symptoms and pharmacology of psychological/psychiatric disorders, as well as the actions of drugs used for their treatment 5. Identify, describe and explain the actions of drugs of abuse and other psychoactive drugs | |||||||||||||||||||||||||||||||||||||||||||
All module information is indicative and subject to change. For further information,students are advised to refer to the University's Marks and Standards and Programme Specific Regulations at: http://www.dcu.ie/registry/examinations/index.shtml |
|||||||||||||||||||||||||||||||||||||||||||
Indicative Content and Learning Activities
Introduction and Principles of Psychopharmacology (e.g., pharmacokinetics and pharmacodynamics)Structure and Function of the Nervous SystemSynaptic Transmission and Signal Transduction (i.e., chemical signalling by neurotransmitters and hormones)Techniques in Neuropharmacology and Behavioural PharmacologyPsychosis, Schizophrenia and Antipsychotic drugsAffective/Mood Disorders and AntidepressantsAnxiety Disorders and AnxiolyticsDrug Abuse, Dependence and AddictionDisorders of Reward, Drug Abuse and Their TreatmentOther Disorders (e.g., disorders of sleep and wakefulness, attention-deficit hyperactivity disorder -ADHD, dementia, etc.) | |||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||
Indicative Reading List
| |||||||||||||||||||||||||||||||||||||||||||
Other Resources None | |||||||||||||||||||||||||||||||||||||||||||